TIVC Stock Analysis
TI
Uncovered
Tivic Health Systems Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Hayward, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The firm is focused on bioelectronic medicine. Tivic Health's product is a non-invasive trigeminal nerve stimulation device sold as ClearUP Sinus Relief (ClearUP) is a handheld device uses ultra-low current electrical waves to relieve symptoms of sinus and nasal inflammation. The company has brought bioelectronic medicine to the home treatment market for nasal allergies, sinus infections, chronic sinusitis, cold and flu. The firm is developing second-generation version of ClearUP, ClearUP Gen 2 for market. Its two ongoing product candidates include npdPP, an at home-use device for treating postoperative pain after sinus surgery, and npdMI, an at home-use device for treating migraine headaches. Tivic Health sells its products direct-to-consumer through its own Websites, Amazon.com and Walmart.com and also sells to United States online retailers such as BestBuy.com and FSAStore.com.